Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency-Reference-Cited by-同舟云学术

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

Published:2018-10-03 Issue:3 Volume:78 Page:431-433
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Briand Coralie,Frémond Marie-Louise,Bessis Didier,Carbasse Aurélia,Rice Gillian I,Bondet Vincent,Duffy Darragh,Chatenoud Lucienne,Blanche Stéphane,Crow Yanick J,Neven Bénédicte

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference7 articles.

1. Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview

2. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

3. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus

4. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study

5. Detection of interferon alpha protein reveals differential levels and cellular sources in disease

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism and target treatment of primary immunodeficiency diseases with systemic lupus erythematosus‐like phenotype;Pediatric Discovery;2024-05-27

2. Vasculitis and vasculopathy associated with inborn errors of immunity: an overview;Frontiers in Pediatrics;2024-01-31

3. Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis;Autoimmunity Reviews;2023-12

4. Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib;Pediatric Rheumatology;2023-10-12

5. Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response;iScience;2023-07